Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary

Collegium Pharmaceutical

07/08/2025 17:35

Collegium Pharmaceutical Inc COLL.OQ reported quarterly adjusted earnings of 34 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $1.62.  The mean expectation of five analysts for the quarter was for earnings of $1.62 per share. Wall Street expected results to range from $1.50  to $1.71 per share.

Revenue rose 29.4% to $188.00 million from a year ago; analysts expected $180.88 million.

Collegium Pharmaceutical Inc's reported EPS for the quarter was 31 cents​.

The company reported quarterly net income of $11.98 million.

Collegium Pharmaceutical Inc shares had risen by 0.6% this quarter and gained 3.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had fallen by about 1.3% in the last three months.​

In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Collegium Pharmaceutical Inc is $46.00, about 35.3% above its last closing price of $29.75

This summary was machine generated from LSEG data August 7 at 04:34 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Jun. 30 2025
1.62
0.34
Missed
Mar. 31 2025
1.43
1.49
Beat
Dec. 31 2024
1.54
1.77
Beat
Sep. 30 2024
1.59
1.61
Beat